Enrichment and Purging of Stem Cells in the Treatment of Non-Hodgkin's Lymphoma
To evaluate the role of purging the hematopoietic cell graft on outcomes for non-Hodgkin's Lymphoma.
Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.
- procedure : high dose chemo then auto hematopoietic cell transplant
Ages Eligible For Study:
- relapsed NHL